Nuklearmedizinische Diagnostik von Knochenmetastasen

Strobel, K.
November 2009
Praxis (16618157);11/4/2009, Vol. 98 Issue 22, p1293
Academic Journal
Conventional bone scintigraphy is still the standard investigation for the detection of bone metastases, especially in breast and prostate cancer. In unclear scintigraphic uptakes in the appendicular skeleton conventional x-rays are problem solving in most of the cases. In unclear uptakes in the axial skeleton additional performance of SPECT/CT can increase the specificity. Fluoride-PET/CT is superior to conventional bone scintigraphy but is not yet available in clinical routine. Patients with high-risk breast cancer and patients with lung cancer should be staged with FDG-PET/CT primarily. An additional bone scan is than superfluous. The great advantage of FDG-PET/CT is the fact that bone metastases and organ metastases can be detected in the same investigation. There is a clear trend of shifting patients from conventional nuclear medicine to PET/CT.


Related Articles

  • Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography Ak, İlknur; Sivrikoz, Muammer Cumhur; Entok, Emre; Vardareli, Erkan // European Journal of Cardio-Thoracic Surgery;Apr2010, Vol. 37 Issue 4, p792 

    Abstract: Objective: At present, metastatic bone involvement is usually assessed using bone scintigraphy, which has a high sensitivity but a poor specificity. The objective of our study was to compare the sensibility of the 2-deoxy-2-[18F] fluoro-d-glucose positron emission tomography/computed...

  • The Semiquantitative Bone Scintigraphy Index Correlates With Serum Tartrate-Resistant Acid Phosphatase Activity in Breast Cancer Patients With Bone Metastasis. Shih-Hung Tsai; Ching-Yuan Chen; Chih-Hung Ku; Janckila, Anthony J.; Yam, Lung T.; Jyh-Cherng Yu; Kai-Wen Chuang; Tsu-Yi Chao // Mayo Clinic Proceedings;Aug2007, Vol. 82 Issue 8, p917 

    OBJECTIVE: To determine if a correlation exists between the semi- quantitative bone scintigraphy index (SQBSI) and serum tartrate- resistant acid phosphatase 5b (TRACP5b) activity, a novel osteociast marker that has been shown to be useful for monitoring bone metastasis in breast cancer (BC)...

  • Bone scintigraphy in osseous sarcoidosis. Cengiz, Arzu; Şaki, Hatice; Yürekli, Yakup // Indian Journal of Nuclear Medicine;Apr2012, Vol. 27 Issue 2, p130 

    Sarcoidosis is a systemic, granulomatous disorder that affects multiple organ systems, but most often the lungs and the skin. The incidence of radiographically evident osseous involvement is between 1% and 13%, with an average of 5% on conventional imaging. Sarcoidosis generally involves the...

  • Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer. Hahn, Steffen; Heusner, Till; Kümmel, Sherko; Köninger, Angelika; Nagarajah, James; Müller, Stefan; Boy, Christian; Forsting, Michael; Bockisch, Andreas; Antoch, Gerald; Stahl, Alexander // Acta Radiologica;Nov2011, Vol. 52 Issue 9, p1009 

    Background: Bone scintigraphy is the standard procedure for the detection of bone metastases in breast cancer patients. FDG-PET/CT has been reported to be a sensitive tool for tumor staging in different malignant diseases. However, its accuracy for the detection of bone metastases has not been...

  • Advantages of diagnostic nuclear medicine. Jimenez, Carlos E. // Physician & Sportsmedicine;Dec99, Vol. 27 Issue 13, p51 

    Part 2. Discusses the impact of advances in nuclear medicine in the detection and localization of very small abnormalities. Radionuclide imaging of myocardial perfusion for detecting coronary artery disease in patients; Use of scintigraphy; Uses of positron-emission tomography and imaging with...

  • PET and PET/CT: Conceptions, Misconceptions, and a Potential New Paradigm for Enhanced Metabolic Imaging. Grossman, Zachary D. // Current Medical Imaging Reviews;2010, Vol. 6 Issue 1, p23 

    As FDG-PET and FDG-PET/CT have gained acceptance, a number of beliefs regarding these techniques have become ingrained in clinicians; the time has come to challenge some of these beliefs, to better serve our patients and perhaps create room for novel ideas that may enhance metabolic imaging....

  • Relevancia de la medicina nuclear en el diagnóstico y tratamiento del paraganglioma maligno. Aguilar-Olivos, Nancy Edith; García-Ortiz, José Rafael; Rojas-Reyna, Guillermo Alfonso; Chaparro-González, Juan Manuel; Weisser-Jacobs, Fred; Oria-Hernández, Jesús // Cirugia y Cirujanos;may/jun2009, Vol. 77 Issue 3, p233 

    Background: Paragangliomas are neoplasms of the chromaffin tissue characterized by the synthesis and/or secretion of catecholamines. Their treatment depends on the extension and functional characteristics of the tumor. In this pathology, the anatomic and functional diagnostic evaluations...

  • Polyostotic Paget's disease mimicking multiple skeletal metastases in planar bone scintigraphy in a patient with carcinoma of breast. Kalawat, Tekchand; Batchu, Suneetha; Parthasarathy, Ravi; Bathala, Chandrasekhar // Indian Journal of Nuclear Medicine;Jan2012, Vol. 27 Issue 1, p50 

    The author describes the utility of serial bone scintigraphy to rule out metastatic bone disease in a patient with carcinoma of breast with Paget's disease mimicking multiple skeletal metastases.

  • Imaging.  // Current Medical Literature: Breast Cancer;2010, Vol. 22 Issue 4, p137 

    The article discusses research being done on positron emission tomography (PET). It references the study "Integrated Positron Emission Tomography/Computed Tomography May Render Bone Scintigraphy Unnecessary to Investigated Suspected Metastatic Breast Cancer," by P. G. Morris and colleagues,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics